GSK plc (GSK,GSK.L) announced the European Commission's approval of Shingrix in a prefilled syringe. The current vaccine presentation comprises two vials. The company said the new prefilled syringe simplifies the vaccine administration process for healthcare professionals. The approval is based on data confirming technical comparability between the prefilled syringe and the existing vaccine presentation.
Tony Wood, Chief Scientific Officer, GSK, said: "This new presentation of Shingrix has been designed to improve ease of administration, helping healthcare professionals to provide protection against shingles."
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.